About Canchip
Canchip is a Healthcare company based in Potsdam (Germany) founded in 2023. It develops tumor-on-a-chip technology to replicate tumor environments for drug testing. It operates on a B2B model. Canchip offers products and services including Tumor-on-Chip Technology and 3D-Printed Microfluidic Devices. Its focus areas include Medical Devices, Microfluidics, 3D-Printed Tools and Biotechnology. Its legal entity is CanChip GmbH.
Company details
CanChip specializes in creating tumor-on-a-chip models that mimic the tumor microenvironment using 3D cell culture and microfluidic systems. This technology accelerates drug screening and supports cancer treatment development through collaborations with universities and research centers. Based in Potsdam, Germany, the company focuses on bridging basic research and clinical applications, enhancing efficiency in oncology studies while reducing costs and time for personalized therapies.
- Headquarters Potsdam, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website canchip.org
- Social LinkedIn
- Legal Name Canchip Gmbh
Products & Services of Canchip
Canchip offers a comprehensive portfolio of products and services, including Tumor-on-Chip Technology and 3D-Printed Microfluidic Devices.
Replicates tumor microenvironment for drug screening and research applications.
Facilitates drug absorption validation in cancer models for enhanced testing.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Canchip
Canchip was founded in 2023.
Canchip is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
CanChip specializes in creating tumor-on-a-chip models that mimic the tumor microenvironment using 3D cell culture and microfluidic systems. This technology accelerates drug screening and supports cancer treatment development through collaborations with universities and research centers. Based in Potsdam, Germany, the company focuses on bridging basic research and clinical applications, enhancing efficiency in oncology studies while reducing costs and time for personalized therapies.
Canchip offers Tumor-on-Chip Technology and 3D-Printed Microfluidic Devices.
Canchip operates through Canchip Gmbh.